栗原 啓

Medicine & Life Sciences

1. Pancreas Transplantation 100%
2. Transplants 33%
3. Kidney Transplantation 33%
4. Japan 31%
5. Tissue Donors 28%
6. Pancreas 26%
7. Graft Survival 26%
8. Brain Death 24%
9. Islets of Langerhans Transplantation 23%
10. Transplantation 22%
11. Type 1 Diabetes Mellitus 19%
12. Propensity Score 17%
13. Registries 17%
14. Chronic Kidney Failure 16%
15. Transplant Recipients 16%
16. Glucagon 15%
17. Kidney 13%
18. Survival Rate 12%
19. Plasmapheresis 11%
20. Coronavirus 11%
21. C-Peptide 10%
22. Hepatic Artery 10%
23. Intravenous Immunoglobulins 10%
24. Nursing Staff 10%
25. Hematopoietic Stem Cell Transplantation 9%
26. Diabetic Nephropathies 9%
27. Immunosuppressive Agents 9%
28. Anesthesiologists 9%
29. Cell- and Tissue-Based Therapy 8%
30. B-Lymphocytes 7%
31. Survival 7%
32. Glucose Tolerance Test 7%
33. Flow Cytometry 6%
34. History 6%
35. Surgeons 6%
36. Randomized Controlled Trials 6%
37. T-Lymphocytes 5%
38. Quality of Life 5%
39. Pediatrics 5%